Squarepoint Ops LLC Acelrx Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.25 - $2.77 $15,971 - $35,392	-12,777 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.18 - $1.98 $15,076 - $25,298	12,777 New	12,777 $16,000
Q3 2020 Nov 16, 2020	SELL	$1.01 - $1.81 $85,172 - $152,635	-84,329 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.03 - $1.69 $86,858 - $142,516	84,329 New	84,329 $102,000
Q1 2020 May 15, 2020	SELL	$0.76 - $2.07 $30,086 - $81,947	-39,588 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.66 - $2.4 $65,716 - $95,011	39,588 New	39,588 $84,000
Q2 2019 Aug 14, 2019	SELL	$2.1 - $3.93 $34,509 - $64,581	-16,433 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.35 - $3.83 $38,617 - $62,938	16,433 New	16,433 $57,000
Q1 2018 May 15, 2018	SELL	$1.7 - $2.35 $27,540 - $38,070	-16,200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.75 - $5.5 $40,556 - $127,462	-23,175 Reduced 58.86%	16,200 $33,000
Q3 2017 Nov 14, 2017	BUY	$2.9 - $4.6 $114,187 - $181,125	39,375	39,375 $181,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.